Frontlight ResearchEarly access
Trial site
Fondazione Salvatore Maugeri Clinica Del Lavoro E Della Riabilitazione
- 1running trial
- 4closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Chronic kidney disease2 trials
- IgA nephropathy2 trials
- Thyroid cancer1 trial
- Phase
- Phase 33 trials
- Phase 22 trials
- Status
- Completed4 trials
- Recruiting1 trial
- Lead sponsor
- Bayer2 trials
- Istituti Clinici Scientifici Maugeri SpA1 trial
- Otsuka Pharmaceutical Development & Commercialization, Inc.1 trial
- Travere Therapeutics, Inc.1 trial
Running trials
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Thyroid cancer1 recruiting
Closed trials
Completed
Active, not recruiting
Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)
Completed
Completed
A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy
Site data: EU CTIS (euclinicaltrials.eu)Updated 12 Nov 2026